Rachel Fynvola Tyndale

49PUBLICATIONS

92CO-AUTHORS

Predictive and prognostic markersMolecular targetsLearning, motivation and emotionChemical engineering designPharmacogenomics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (49)

Sort by Publication Date:

|May 31, 2026

Faster CYP2A6 increases COPD and lung cancer risk by increasing smoking quantity: a mediated mendelian randomization and observational mediation study.

|Jul 09, 2025

Extending Investigations of miR-126-5p on the Regulation of CYP2A6, the Major Nicotine-Inactivating Enzyme.

Weilong Gu, Alec W R Langlois, Haidy Giratallah

|May 13, 2025

Daily Cigarette Abstinence and Smoking Rate With Varenicline: Relationships With Treatment, Craving, and Affect During the First Week of the Quit Attempt.

Sarah S Tonkin, Jennifer M Betts, Ashley N Dowd

|Feb 06, 2025

Evaluating mediators of the effect of varenicline preloading on smoking abstinence in a randomized controlled trial.

Samantha Johnstone, Robert K Cooper, Jennifer M Wray

|Aug 31, 2024

Fine-mapping the CYP2A6 regional association with nicotine metabolism among African American smokers.

Jennie G Pouget, Haidy Giratallah, Alec W R Langlois

|Jul 25, 2024

PharmVar GeneFocus: CYP2A6.

Alec W R Langlois, Meghan J Chenoweth, David Twesigomwe

Pageof 9

Frequent Collaborators

Jo Knight

Meghan J Chenoweth

Robert Schnoll

Neal L Benowitz

Edythe D London

Larry W Hawk

Frank J Gonzalez

Sharon Miksys

Edgor Cole Tolledo

Romina Mizrahi

Frequent Collaborators

Jo Knight

Meghan J Chenoweth

Robert Schnoll

Neal L Benowitz